SNPMiner Trials (Home Page)
Report for Mutation S9346A
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
There is one clinical trial.
Clinical Trials
1 Germline Polymorphisms Associated With the PSA Response in Men With Metastatic Prostate Cancer Treated With Androgen Deprivation Therapy
RATIONALE: Studying samples of blood in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is studying blood samples from patients with metastatic prostate cancer previously treated with bicalutamide and goserelin.
NCT01120262 Prostate Cancer Genetic: gene expression analysis Genetic: polymorphism analysis Other: laboratory biomarker analysis MeSH:Prostatic Neoplasms
HPO:Prostate cancer Prostate neoplasm
S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin RATIONALE: Studying samples of blood in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. --- S9346A ---
Primary Outcomes
Measure: Serum PSA values at 7 months Time: 7 monthsMeasure: Role of genetic variation in response to therapy Time: baseline